His Cancer Meds Were Nearly $1K A Pill. How Did That Happen?
Fresh Air
00:00
Intro
This chapter discusses the impact of an executive order on NPR's funding while also delving into a personal story of a cancer diagnosis. It critically examines the high costs and ethical concerns surrounding the drug Revlimid, drawing parallels to its controversial history.
Transcript
Play full episode
